end up in the formation of collateral vessels. Varices can involve the whole gastrointestinal tract and are a frequent source of bleeding. 
soidal, or postsinusoidal level. Major causes are depicted in table 1 . If the block arises outside the liver or portal vein, the term 'partial' or 'isolated' portal hypertension is used; it is mainly caused by thrombosis of the splenic vein, e.g. following necrosing pancreatitis. Although patients with this condition can develop gastric or esophageal varices as well, they usually do not show other characteristic signs of portal hypertension.
To estimate the severity of portal hypertension, invasive measurements by the wedged hepatic venous pressure can be performed. An elevation 6 12 mm Hg is associated with an increased risk of variceal bleeding; however, in the presence of a prehepatic or presinusoidal block, these measurements fail to indicate portal hypertension. Here, direct invasive or noninvasive measurements of variceal pressure are preferred.
From a mechanistic view, portal pressure (pP) may become elevated by increases in blood fl ow (Q) and/or increase in resistance (R): ⌬ pP = Q (accounting for about 40%) ! R (accounting for about 60%).Typical changes are shown in fi gure 1 .
The regulation of the splanchnic arterioles, which are partially constricted under normal conditions, underlies In the splanchnic system, arterioles are about 10 times more potent in regulating overall pressure than venules (in contrast to other body compartments where a 1: 1 ratio is observed). A variety of metabolic end-products (e.g. adenosine), some endothelium-derived substances (e.g. NO), and certain neurotransmitters (e.g. acetylcholine) are known to relax the tone and thus produce vasodilation. Important vasoconstrictor infl uences on splanchnic arterioles include circulating agents (e.g. angiotensin), endothelium-derived substances (e.g. endothelin), and again neurotransmitters (norepinephrine). An overview is given by table 2 . If smooth muscle tension is the controlled variable, intravascular pressure can be understood as a determinant of arteriolar diameter (myogenic regulation), where tension (T) is = intravascular pressure P ! vessel radius r.
Hence, a sudden elevation of portal pressure in an otherwise normal individual elicits the constriction of arterioles in those organs draining blood into the portal vein. However, this holds mainly true for normal conditions and describes acute changes mediated by hypoxia and increased metabolites such as adenosine. In chronic liver disease, the vascular response contrasts with the intense dilation of arterioles that accompanies chronic portal hypertension. Here, the accumulation of vasodilator infl uences (e.g. NO, glucagon) dominate over myogenic vasoconstrictor infl uences that are intrinsic to the splanchnic circulation. As a result, the splanchnic arteriolar diameter is increased, vascular resistance is low and blood fl ow is increased (increased endothelial 'eNOS'-derived NO synthesis, decreasing vascular tone). These changes are accompanied by changes in the hepatic microvasculature. With continuing infl ammation and development of fi bro- Endothelium-derived factors Endothelin 1 via ADH and thrombin NO via L-arginine regulated by acetylcholine, substance P and bradykinin sis, the hepatic parenchyma diminishes and the functional status of the remaining liver cells is additionally impaired by shear stress. This leads to reduced eNOSderived NO synthesis in the liver bed and the microcirculatory NO defi ciency leads to an increase in vascular tone, amplifying the structural changes described. Therefore the balance between vascular tone in the liver and the splanchnic system, although shifting to the opposite direction, will eventually have the same clinical consequence, i.e. the development of portal hypertension. The extrinsic regulation of splanchnic blood fl ow is characterized by the fact that circulating vasoconstrictors are the major contributors to basal splanchnic arteriolar tone: about 60% of total impact is derived from norepinephrine, angiotensin II, and vasopressin. In contrast, in the brain, these factors only account for 5% of total regulation. Next, regulation mediated by circulating vasodilators (glucagon, VIP, substance P) contributes substantially to splanchnic hyperemia in some forms, because impaired liver function will decrease hepatic degradation (e.g. for glucagon). Together with the increased production of reactive autonomous vasodilators such as PGI 2 , this explains why the splanchnic vasculature will become hyporeactive to vasoconstrictors such as norepinephrine, vasopressin, angiotensin II, and endothelin-1. In summary, these factors will increase portal blood fl ow. In comparison, as food ingestion will release the same variety of GI hormones and peptides to produce rapid transient arteriole dilation, liver cirrhosis and other causes of PH will lead to permanent elevation of these factors. The clinical observation that variceal rupture and bleeding often occur after meals can be attributed to the fact that all compensatory mechanisms are already at maximum use and any further increase in blood fl ow will then have a deleterious clinical impact.
However, splanchnic vasodilation has further consequences: signifi cant venous blood pooling develops and is followed by systemic vasodilation and arterial underfi lling. Together with the indirect cause of secondary hyperaldosteronism induced by impaired hepatic degradation, the lack of intravascular volume will activate the renin-angiotensin-aldosterone system, leading to sodium and water retention. This increase in total blood volume will lead to a hyperdynamic state, again increasing portal venous infl ow. These conclusions are supported by animal experiments showing that NOS activity is increased in cirrhosis and that the reversal of primary arterial vasodilation in experimental cirrhosis is possible with NOS inhibition. Furthermore, NOS inhibition in experimental cirrhosis reverses the hyperdynamic circulation, the activation of the neurohumoral axis and sodium and water retention. Summary ( fi g. 3 ) Portal hypertension is caused by either an increase in hepatic vascular resistance or portal venous infl ow. Therefore, structural changes (fi brosis, thrombosis) together with increased vascular tone mediated by intrinsic and extrinsic vasoconstrictors and vasodilators are accompanied by a hyperdynamic state due to arterial underfi lling and secondary fl uid retention. Further consequences of portal hypertension include an increase in blood fl ow which will lead to a hyperdynamic state with fl uid retention, leading to secondary involvement of other organs, such as cirrhotic cardiomyopathy, hepatopulmonary syndrome and hepatorenal syndrome. Finally, portal hypertension will end up in the formation of collateral vessels (varices). The described mechanism(s) provide exciting perspectives for therapeutic interventions that are already established (e.g. ␤ -blockers) or emerging (e.g. endothelin receptor antagonists).
